NCT07140848Recruiting
CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
A Novel Continuous Glucose Monitoring Enhanced DPP Intervention to Prevent Type 2 Diabetes in Adults With Prediabetes
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 22 Aug 2025
- Start date
- 13 Apr 2026
- Primary completion date
- Mar 2028
- Lead sponsor
- State University of New York at Buffalo
- Diseases
- Type 2 diabetes
- NCT number
- NCT07140848
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 13 Apr 2026 to the primary completion date, Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- are currently using CGMs or have medical contraindications to CGM use, such as severe skin allergies or implantable defibrillators, or
Other illness
- have a diagnosis of type 1 or type 2 diabetes,
- are currently enrolled in another clinical trial for prediabetes. Additionally, using validated assessments, we will exclude participants with significant dementia, alcohol or drug abuse/dependency, active psychosis, or life expectancy less than 12 months as these conditions are likely to interfere with adherence to the intervention.
Other
- Individuals will be excluded from the study if they
Who the study is looking for
- adults aged 18 years or older,
- diagnosis of prediabetes, as defined by current clinical guidelines (HbA1c 5.7% to 6.4%, fasting plasma glucose 100-125 mg/dL, or 2-hour plasma glucose 140-199 mg/dL following a 75g oral glucose tolerance test),
- body mass index (BMI) of at least 24 kg/m² (or 22 kg/m² for Asian Americans),
- willingness to comply with all aspects of the study protocol, including attending coaching sessions and using CGM devices.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Division of Population Health, Department of Medicine Coordinator of this site? Confirm its status | Buffalo | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.